NCT05827601

Brief Summary

The project aims at implementing a more pro-active surveillance of potential transmission of influenza viruses to humans (zoonotic transmission). Clinical surveillance of influenza in humans and avian species is well organized and has been operating for decades, but currently there is no pro-active systematic surveillance of potential transmission of animal (avian or swine) influenza viruses to humans, only follow-up of people showing clinical symptoms. People working with potentially infected animals have the highest risk. Moreover, they can represent the first steps in a pandemic: if the virus adapts to humans, infected workers could potentially spread the virus to other people. Currently, highly pathogenic clade2.3.4.4b H5 avian influenza viruses are continuously circulating in wild birds in Belgium and the number of introduction in poultry farms has raised, increasing the contact opportunities with high viral concentrations. Several reports of suspected human infection have been made by different countries. In addition, the virus was detected in sick non-human mammals. The large circulation in wild birds thus represents an increase risk of spill-over to mammalian species, including humans, (by contact directly with wild birds, or via outbreaks in poultry). This increased opportunity for accidental spillover to new host species increases the chances for the avian virus to adapt to mammals, including humans. Likewise, there have also been an increased number of human cases of swine influenza reported by several European countries. A pro-active surveillance aiming at also detecting asymptomatic infections would allow an early detection of transmission that could help to prevent a new pandemic. As a piloting approach during this specific project, some dedicated sentinel networks among at-risk workers will be initiated: people in poultry farms involved with the management of outbreaks of highly pathogenic avian influenza; people working at bird (or more generally wild life) rehabilitation centres or poultry farms; veterinarians working in pig farms/slaughterhouses.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

April 25, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

September 8, 2023

Status Verified

September 1, 2023

Enrollment Period

1.3 years

First QC Date

March 30, 2023

Last Update Submit

September 5, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of sentinel participants positive for a non-seasonal influenza virus

    result of RT-qPCR test to detect and characterize non-influenza viruses

    every 2 weeks through study completion (December 2024)

  • Number of outbreak participants positive for a non-seasonal influenza virus

    result of RT-qPCR test to detect and characterize non-influenza viruses

    every 2 days during 2 weeks after enrollment

Secondary Outcomes (1)

  • Number of outbreak participants with seroconversion against a non-seasonal influenza virus

    at enrollment and about 4 weeks after

Study Arms (4)

Avian Influenza Outbreak Farms

People involved in outbreak management, ranging from poultry farm owners and their family to inspectors through veterinarians and cullers/cleaners, will be invited to take part in the study at the earliest step possible after outbreak detection. Self sampling by nasopharyngeal swab will be requested every 2 days during 2 weeks.

Diagnostic Test: respiratory specimenDiagnostic Test: serum

Poultry Farm Sentinel Network

People working in poultry farms and in contact with animals will be invited to join the cohort. Self sampling by nasopharyngeal swab will be requested every 2 weeks for the whole duration of the study. anticipated: 15

Diagnostic Test: respiratory specimen

Wild bird/life Rehabilitation Centre Sentinel Network

People working in wild bird/life rehabilitation centers and in contact with animals will be invited to join the cohort. Self sampling by nasopharyngeal swab will be requested every 2 weeks for the whole duration of the study. anticipated: 25

Diagnostic Test: respiratory specimen

Pig Industry Veterinarian Sentinel Network

Veterinarians working in the pig industry and in contact with animals will be invited to join the cohort. Self sampling by nasopharyngeal swab will be requested every 2 weeks for the whole duration of the study. anticipated: 15

Diagnostic Test: respiratory specimen

Interventions

respiratory specimenDIAGNOSTIC_TEST

participants will perform self-sampling with a nasopharyngeal swab

Avian Influenza Outbreak FarmsPig Industry Veterinarian Sentinel NetworkPoultry Farm Sentinel NetworkWild bird/life Rehabilitation Centre Sentinel Network
serumDIAGNOSTIC_TEST

participants will be invited to get a blood sample taken by a general practitioner or to perform a self sampling of capillary blood

Avian Influenza Outbreak Farms

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Workers or volunteers of one of the targeted groups within the sites that accept to take part in the study

You may qualify if:

  • worker or volunteer of one of the targeted groups at one of the selected sites and accepting to take part in the study
  • to have regular contacts with animals within job/activity framework
  • being committed to take the regular samples

You may not qualify if:

  • \- people who had a broken nose might have difficulties to perform self-swabbing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sciensano

Brussels, Belgium

Location

Biospecimen

Retention: SAMPLES WITH DNA

respiratory specimens will be registered and stored in the Biobank for 10 years after the end of the study, and could be tested for other pathogens but they will not be used for human genetic or biomarker analyses.

MeSH Terms

Conditions

Influenza, Human

Interventions

Respiratory Rate

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsOrthomyxoviridae InfectionsRNA Virus InfectionsVirus DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Belgian National Influenza Centre

Study Record Dates

First Submitted

March 30, 2023

First Posted

April 25, 2023

Study Start

September 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

September 8, 2023

Record last verified: 2023-09

Locations